FDA Drug Recalls

Recalls / Class II

Class IID-0726-2023

Product

heparin added to 0.9% sodium chloride, 7,500 units/1,000 mL* (7.5 units/mL), 1000 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-7009-1.

Affected lot / code info
Lot # 37-888668, 37-888685, 37-888701, Exp 05/02/2023; 37-890550, 37-890556, Exp 05/09/2023; 37-892201, 37-892216, Exp 05/16/2023; 37-893866, 37-893917, 37-893918, Exp 05/23/2023; 37-895705, 37-895717, Exp 05/30/2023

Why it was recalled

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Recalling firm

Firm
Central Admixture Pharmacy Services, Inc.
Notification channel
E-Mail
Type
Voluntary: Firm initiated
Address
6580 Snowdrift Rd Ste 100, N/A, Allentown, Pennsylvania 18106-9331

Distribution

Quantity
3055 bags
Distribution pattern
Nationwide in the USA.

Timeline

Recall initiated
2023-04-28
FDA classified
2023-05-19
Posted by FDA
2023-05-31
Terminated
2025-06-22
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0726-2023. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.